[1] [1] GOEDERT M, SPILLANTINI M G, CAIRNS N J, et al. Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms［J］. Neuron, 1992, 8(1): 159-168.

[2] [2] ISING C, STANLEY M, HOLTZMAN D. Current thinking on the mechanistic basis of Alzheimer’s and implications for drug development［J］. Clinical Pharmacology and Therapeutics, 2015, 98(5): 469-471.

[3] [3] SELKOE D J. The therapeutics of Alzheimer’s disease: where we stand and where we are heading［J］. Annals of Neurology, 2013, 74(3): 328-336.

[4] [4] SEVIGNY J, CHIAO P, BUSSIERE T, et al. The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease［J］. Nature, 2016, 537(7618): 50-56.

[5] [5] ABBOTT A, DOLGIN E. Failed Alzheimer’s trial does not kill leading theory of disease［J］. Nature, 2016, 540(7631): 15-16.

[6] [6] PROKOP S, MILLER K R, HEPPNER F L. Microglia actions in Alzheimer’s disease［J］. Acta Neuropathologica, 2013, 126(4): 461-477.

[7] [7] FU H, LIU B, FROST J L, et al. Complement component C3 and complement receptor type 3 contribute to the phagocytosis and clearance of fibrillar Aβ by microglia［J］. Glia, 2012, 60(6): 993-1003.

[8] [8] VARNUM M M, IKEZU T. The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer’s disease brain［J］. Archivum Immunologiae et Therapiae Experimentalis, 2012, 60(4): 251-266.

[9] [9] PAASILA P J, DAVIES D S, KRIL J J, et al. The relationship between the morphological subtypes of microglia and Alzheimer’s disease neuropathology［J］. Brain Pathology, 2019, 29(6): 726-740.

[11] [11] STOROZHUKA M, CHERNINSKYIA A, MAXIMYUKA O, et al. Acid-sensing ion channels: focus on physiological and some pathological roles in the brain［J］. Current Neuropharmacology, 2021, 19(9): 1570-1589.

[12] [12] SONDAG C M, DHAWAN G, COMBS C K. Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia［J］. Journal of Neuroinflammation, 2009, 6(1): 1-13.

[13] [13] NG J, KAUR H, COLLIER T, et al. Site-specific glycations of Aβ1-42 affect fibril formation and are neurotoxic［J］. Journal of Biological Chemistry, 2019, 294(22): 8806-8818.

[14] [14] BUTTERFIELD D A, BOYD-KIMBALL D, PERRY G, et al. Oxidative stress, amyloid-β peptide, and altered key molecular pathways in the pathogenesis and progression of Alzheimer’s disease［J］. Journal of Alzheimer’s Disease, 2018, 62(3): 1345-1367.

[15] [15] BENILOVA I, KARRAN E, STROOPER B D. The toxic Aβ oligomer and Alzheimer’s disease: an emperor in need of clothes［J］. Nature Neuroscience, 2012, 15(3): 349-357.

[16] [16] CHENG Y, TIAN D Y, WANG Y J. Peripheral clearance of brain-derived Aβ in Alzheimer’s disease: pathophysiology and therapeutic perspectives［J］. Translational Neurodegeneration, 2020, 9(1): 16.

[17] [17] TREMBLAY M E, STEVENS B, SIERRA A, et al. The role of microglia in the healthy brain［J］. Journal of Neuroscience, 2011, 31(45): 16064-16069.

[18] [18] SARLUS H, HENEKA M T. Microglia in Alzheimer’s disease［J］. The Journal of Clinical Investigation, 2017, 127(9): 3240-3249.

[20] [20] TOMUAR H, MOGI C, SATO K, et al. Proton-sensing and lysolipid-sensitive G-protein-coupled receptors: a novel type of multi-functional receptors［J］. Cellular Signalling, 2005, 17(12): 1466-1476.

[21] [21] WEMMIE J A, CHEN J, ASKWITH C C, et al. The acid-activated ion channel ASIC contributes to synaptic plasticity, learning, and memory［J］. Neuron, 2002, 34(3): 463-477.

[22] [22] CHU X P, XIONG Z G. Physiological and pathological functions of acid-sensing ion channels in the central nervous system［J］. Current Drug Targets, 2012, 13(2): 263-271.

[23] [23] VERGO S, CRANER M J, ETZENSPERGER R, et al. Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model［J］. Brain, 2011, 134(Pt 2): 571-584.

[24] [24] SUN X, CAO Y B, HU L F, et al. ASICs mediate the modulatory effect by paeoniflorin on α-synuclein autophagic degradation［J］. Brain Research, 2011, 1396: 77-87.

[25] [25] YU X W, HU Z L, NI M, et al. Acid-sensing ion channels promote the inflammation and migration of cultured rat microglia［J］. Glia, 2015, 63(3): 483-496.

[26] [26] HENEKA M T, KUMMER M P, STUTZ A, et al. NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice［J］. Nature, 2013, 493(7434): 674-678.

[27] [27] HE P, ZHONG Z, KRISTINA L, et al. Deletion of tumor necrosis factor death receptor inhibits amyloid β generation and prevents learning and memory deficits in Alzheimer’s mice［J］. Journal of Cell Biology, 2007, 178(5): 829-841.